Neurodevelopmental outcomes in congenital and perinatal infections
- PMID: 37466092
- PMCID: PMC10530333
- DOI: 10.1097/QCO.0000000000000946
Neurodevelopmental outcomes in congenital and perinatal infections
Abstract
Purpose of review: Congenital infections are a major cause of childhood multidomain neurodevelopmental disabilities. They contribute to a range of structural brain abnormalities that can cause severe neurodevelopmental impairment, cerebral palsy, epilepsy, and neurosensory impairments. New congenital infections and global viral pandemics have emerged, with some affecting the developing brain and causing neurodevelopmental concerns. This review aims to provide current understanding of fetal infections and their impact on neurodevelopment.
Recent findings: There are a growing list of congenital infections causing neurodevelopmental issues, including cytomegalovirus, Zika virus, syphilis, rubella, lymphocytic choriomeningitis virus, and toxoplasmosis. Fetal exposure to maternal SARS-CoV-2 may also pose risk to the developing brain and impact neurodevelopmental outcomes, although studies have conflicting results. As Zika virus was a recently identified congenital infection, there are several new reports on child neurodevelopment in the Caribbean and Central and South America. For many congenital infections, children with in-utero exposure, even if asymptomatic at birth, may have neurodevelopmental concerns manifest over time.
Summary: Congenital infections should be considered in the differential diagnosis of a child with neurodevelopmental impairments. Detailed pregnancy history, exposure risk, and testing should guide diagnosis and multidisciplinary evaluation. Children with congenital infections should have long-term follow-up to assess for neurodevelopmental delays and other neurosensory impairments. Children with confirmed delays or high-risk should be referred for rehabilitation therapies.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest
Sarah B. Mulkey has received grant support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01HD102445. Dr. Mulkey also has a contract with the U.S. Centers for Disease Control and Prevention, for work on Zika virus separate from this study. Olivier Fortin has no conflict of interest to declare.
Figures
References
-
- Wilson CB, Nizet V, Maldonado YA et al. Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant. 8th ed. Philadelphia: W.B. Saunders; 2015.
-
-
Grosse SD, Dollard SC, Ortega-Sanchez IR. Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies. Semin Perinatol 2021; 45:151393.
* Recent economic analysis of the impacts of cCMV.
-
-
- Barros Faiçal AV, de Oliveira JMGC, Andrade NC et al. Socioemotional Status of Children With Uterine Exposure to the Zika Virus. Pediatr Neurol 2020; 103:86–88. - PubMed
-
-
Ssentongo P, Hehnly C, Birungi P et al. Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening: A Systematic Review and Meta-analysis. JAMA Netw Open 2021; 4:e2120736.
* Large meta-analysis of cCMV epidemiology in countries that introduced universal screening.
-
-
- Ngalame AN, Mubiana-Mbewe M, Dionne JA. Genital Tract Infections in Women, Pregnancy and Neonates. Obstet Gynecol Clin North Am 2022; 49:751–769. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
